Publications by authors named "An-Na Moon"

Claim this Profile
I
Improvement of NASH and liver fibrosis through modulation of the gut-liver axis by a novel intestinal FXR agonist.
An-Na Moon, François Briand, Natalia Breyner, Dong-Keun Song, Martin Rønn Madsen

Biomed Pharmacother· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety.
Myongjae Lee, In-Gyu Je, Jeong Eun Kim, Yeongran Yoo, Jong-Ha Lim, An-Na Moon

Mol Cancer Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Dual Adenosine A and A Receptor Antagonists with 1-Pyrazolo[3,4]pyrimidin-6-amine Core Scaffold as Anti-Parkinson's Disease Agents.
Juyoung Jung, Yoonsuk Lee, An-Na Moon, Jihyae Ann, Jin Ju Jeong

Pharmaceuticals (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel heat shock protein (Hsp90) inhibitors based on luminespib with potent antitumor activity.
Juyoung Jung, Jinsun Kwon, Soojung Hong, An-Na Moon, Jinah Jeong

Bioorg Med Chem Lett· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New non-quinone geldanamycin analogs from genetically engineered Streptomyces hygroscopicus.
Cheng-Zhu Wu, An Na Moon, Jae-Hyuk Jang, Dongho Lee, Sun-Young Kang

J Antibiot (Tokyo)· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Alkylsalicylic acid analogues inhibit in vitro ATPase activity of heat shock protein 90.
Cheng-Zhu Wu, An Na Moon, Oksik Choi, Sun-Young Kang, Jung Joon Lee

Arch Pharm Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis